Introduction
Previous clinical studies have reported that clinical outcomes after myocardial revascularization are significantly worse in diabetic patients than in non-diabetic patients [1] [2] [3] [4] [5] . Hemoglobin A1c (HbA1c) is a convenient and wellknown biomarker in clinical practice. Indeed, observational studies have revealed that HbA1c level correlates with increased cardiovascular events in primary and secondary populations [6, 7] . However, the prognostic value of HbA1c level in diabetic patients remains controversial, particularly among patients with advanced coronary atherosclerotic disease [8] [9] [10] . This study aimed to investigate the impact of preoperative HbA1c level on diabetic patients after coronary artery bypass grafting (CABG), particularly off-pump CABG (OPCAB).
Methods

Study patients
Of 893 patients undergoing primary isolated OPCAB at Juntendo University Hospital from July 2002 to December 2007, subjects comprised 311 diabetic patients at the time of admission. Diabetes mellitus was defined as continuous plasma glucose level ≥200 mg/dl, fasting plasma glucose level ≥126 mg/dl, 2-h plasma glucose levels in the 75 g oral glucose tolerance test ≥200 mg/dl, HbA1c level ≥6.5%, or treatment with oral hypoglycemic drugs or insulin injection. Five cases were excluded because preoperative HbA1c levels could not be obtained. Demographic data [including age, gender and body mass index (BMI)], coronary risk factors (hypertension, fasting total cholesterol, lowdensity lipoprotein, high-density lipoprotein cholesterol, triglycerides, fasting plasma glucose, smoking history, and family history of coronary artery disease), other comorbidities (hemodialysis, cerebral infarction, and history of malignancy), medication use, and operative parameters were prospectively recorded. Patients were divided into 3 groups according to the preoperative HbA1c levels: standard, HbA1c <6.5%; moderate, HbA1c ≥6.5% but <7.5%; or high, HbA1c ≥7.5%. This study was approved by the Internal Review Board in our hospital and all procedures were performed according to the Helsinki Declaration.
Surgical technique
OPCAB was determined as the primary strategy for isolated coronary artery disease except educational cases, cases with unstable hemodynamics, and cases requiring multiple on-lay anastomoses for diffuse calcified lesions. The grafting strategy was determined by several surgeons in our department according to the patient background, perioperative conditions and angiographic findings. OPCAB was performed under normothermia with warm intravenous fluids administration. All cases underwent OPCAB without conversion to on-pump CABG.
Median sternotomy was used to expose the heart. The pericardium was opened with an inverted T-shaped incision after harvesting the internal mammary arteries. Arterial grafts were harvested as skeletonized conduits using an ultrasonic scalpel (Harmonic Scalpel; Ethicon Endosurgery, Cincinnati, OH, USA). After placing deep pericardial sutures to expose target coronary vessels, the heart was stabilized with a suction-irrigation tissue stabilization system (Octopus 3; Medtronic, Minneapolis, MN, USA). In cases involving long anastomosis or ineffective proximal snaring, intracoronary shunt was used. Anastomosis of the saphenous vein to the ascending aorta was performed with side clamping. No proximal anastomotic assist devices were utilized.
Outcomes
The primary endpoints were all-cause mortality and cardiac mortality. Cardiac mortality was defined as death from myocardial infarction (MI), arrhythmia, congestive heart failure, or sudden death. The secondary endpoint was to compare perioperative morbidity. Survival data were collected by serial contact with patients or their families by telephone interview. Details of mortality and morbidity were obtained from the medical records of our hospitals or by direct contact with follow-up physicians. Confirmation of survival was performed between January 1 and February 27, 2009.
Statistical analysis
Statistical analyses were performed using JMP version 8 software (SAS Institute Inc., Cary, NC, USA). In the comparison of patient characteristics and operative outcomes, categorical data are expressed as frequencies and percentages, and continuous variables are expressed as mean ± standard deviation. These data were compared using the 2 -test in case of categorical variables and continuous variables were compared using analysis of variance among 3 groups. Survival curves were constructed for each group using Kaplan-Meier's methods and compared by log-rank testing. p-Values less than 0.05 were considered statistically significant. The efficacy of preoperative HbA1c level after OPCAB for predicting all-cause mortality was determined using multivariate Cox's proportional-hazards regression analysis. The model was adjusted for the risk factors that were significant at a 0.20 level in the univariate analysis. Then, the interaction between each risk factor and preoperative HbA1c was tested at a 0.05 level. BMI was dropped from the model due to non-significant interaction.
Results
All 306 patients were followed during the entire study period. HbA1c level was defined as standard in 115 patients (mean, 5.8 ± 0.4%), moderate in 96 patients (mean, 6.9 ± 0.3%), and high in 95 patients (mean, 8.5 ± 0.9%). Baseline characteristics and angiographic findings were similar among the 3 groups (Table 1 ). Significant differences in preoperative triglyceride and fasting blood sugar levels were identified. One patient in the moderate HbA1c group showed triglycerides >1300 mg/dl. A total of 89 patients had been on insulin therapy (standard, n = 21, 18.3%; moderate, n = 26, 27.1%; high, n = 42, 44.2%; p = 0.0002), 143 patients were on oral hypoglycemic agents (standard, n = 50, 43.5%; moderate, n = 53, 55.2%; high, n = 39, 41.1%; p = 0.11), and 72 patients had received diet therapy alone (standard, n = 43, 35.7%; moderate, n = 16, 16.7%; high, n = 13, 13.7%; p < 0.0001) ( Table 2 ). The number of distal anastomoses was similar among the 3 groups (standard, 4.0 ± 0.1; moderate, 4.0 ± 0.1; high, 4.0 ± 0.1; p = 0.80). Only 2 patients in the moderate HbA1c group did not undergo arterial grafting with internal mammary artery (normal, n = 115, 100%; moderate, n = 94, 97.9%; high, n = 95, 100%; p = 0.18). Operation time (standard, 322 ± 74 min; moderate, 336 ± 83 min; high, 334 ± 84 min; p = 0.40) also did not differ significantly among the 3 groups (Table 3) . 
Perioperative outcomes
No significant difference in frequency of perioperative complications was seen among the 3 groups, although frequency tended to be higher in the high HbA1c group. Complications included stroke in 2 cases (2.1%), mediastinitis in 2 cases (2.1%), and low output syndrome in 1 case (1.1%). Arrhythmia (standard, n = 12, 10.4%; moderate, n = 9, 9.4%; high, n = 16, 16.8%; p = 0.23) was paroxysmal atrial fibrillation in all except 1 case of ventricular tachycardia in standard HbA1c group. MI, pneumonia, and gastrointestinal complications did not occur among the 3 groups perioperatively (Table 4 ). In addition, no patients died during 30 days postoperatively.
Long-term outcomes
Mean duration of follow-up was 3.6 ± 1.7 years. During follow-up, 19 patients died (6.2%), including 4 cardiac deaths (1.3%). Mortality due to causes other than cardiac death included cerebrovascular disease in 4 cases (21.1%), malignancy in 8 cases (42.1%), renal failure in 1 case (5.3%), pneumonia in 1 case (5.3%), and gastrointestinal bleeding in 1 case (5.3%). Cardiac death included acute MI in 2 cases (50.0%) and congestive heart failure in 2 cases (50.0%).
Cumulative survival curves for all-cause mortality are shown in Fig. 1 . Log-rank testing showed no significant difference among the 3 groups (p = 0.26). Cumulative survival curves for cardiac mortality are shown in Fig. 2 . No significant difference was apparent among the groups (p = 0.17). Risk analyses using Cox's proportional-hazard modeling are indicated in Table 5 . Age was the only significant risk factor for all-cause mortality.
Discussion
Our study showed that preoperative HbA1c level was not associated with long-term mortality among diabetic patients undergoing OPCAB. A unique feature of this study was the inclusion of only patients who underwent OPCAB, which is performed more popularly in Japan than in other countries [11] . We have reported diabetes mellitus as an independent risk factor for cardiovascular events after CABG [12] . In our previous reports, we showed no data from diabetic patients Figure 1 Kaplan-Meier's curves for all-cause mortality according to the preoperative hemoglobin (Hb) A1c levels of diabetic patients undergoing off-pump coronary artery bypass grafting. Standard level (HbA1c <6.5%) vs. moderate level (HbA1c ≥6.5% but <7.5%) vs. high level (HbA1c ≥7.5%). 
Figure 2
Kaplan-Meier's curves for cardiac mortality according to the preoperative hemoglobin (Hb) A1c levels.
regarding the effect of baseline glucose control on long-term outcomes. To the best of our knowledge, this is the first study to report the impact of preoperative HbA1c level on mortality in diabetic patients undergoing OPCAB. Diabetic management using HbA1c level was utilized for control in our daily clinical practice. In addition, the EPICNorfolk study demonstrated that HbA1c level correlated with increased cardiovascular events in a local community follow-up study [6] . That observational study included primary care patients. Consistent with that study, Elley et al. reported increased HbA1c as an independent risk factor for cardiovascular disease in a large prospective cohort of type 2 diabetes patients without cardiovascular disease [7] . These studies indicating correlations between elevated HbA1c and adverse outcomes were prospective cohort studies for normal populations or patients with type 2 diabetes without cardiovascular disease. Our study differs from those studies in that patients required coronary revascularization, suggesting that these patients displayed advanced coronary artery disease with higher levels of co-morbidity.
In terms of prognostic value after coronary revascularization, Corpus et al. demonstrated an association between HbA1c and major adverse cardiac events in non-diabetic patients undergoing percutaneous coronary intervention (PCI) [13] . They suggested HbA1c levels of 6-7% as a significant independent predictor of major adverse cardiac events after PCI. O'Sullivan et al. also suggested that HbA1c levels of 6-7% may have prognostic significance in nondiabetic patients undergoing vascular surgery [8] . Halkos et al. showed the impact of elevated preoperative HbA1c level after CABG among over 3000 patients [9, 14] . Perioperatively, for each unit increase in HbA1c, risks of MI and deep sternal wound infection increased significantly. As for long-term survival, patients with HbA1c ≥7% showed lower unadjusted 5-year survival compared to patients with HbA1c <7%. However, the subjects of the large study included both diabetic and non-diabetic patients. Indeed, no difference in 5-year mortality was observed among diabetic patients according to the HbA1c levels ≥7% compared to <7% on the unadjusted analysis. We considered that the impact of preoperative HbA1c level on long-term outcomes seemed to be different between non-diabetic and diabetic patients considerably. In terms of non-diabetic patients, preoperative HbA1c reflected their potential glucose tolerance, whereas the value of diabetes implied the efficacy of their treatments as well as impaired glucose tolerance.
Various explanations for the lack of predictive value of preoperative HbA1c for long-term outcomes have been mentioned as follows. Firstly, it may be too late to prevent macrovascular complications in diabetic patients with advanced coronary artery disease requiring CABG. Greenfield et al. reported that diabetic patients with high levels of comorbidity may receive diminished cardiovascular benefit from intensive glucose control [10] . Thus, we consider that early intervention for diabetes is necessary to acquire some benefit.
Then, the morbidity and mortality rates were lower in our study than in previous studies [9] . Severe wound infection has been established as a crucial perioperative complication among patients with poor glycemic control [15, 16] . In the present study, two cases of mediastinitis occurred only in the group of high HbA1c, however our multidisciplinary approach might avoid fatal outcomes. Moreover, no 30-day or in-hospital deaths were encountered in our study. We considered that this might be one of the reasons why the high HbA1c group showed the better long-term survival unexpectedly. Finally, the patients with high preoperative HbA1c might be treated intensively and tightly after operation than those with well-controlled HbA1c.
This study shows several limitations. This was not a randomized control study. The subjects in this study comprised a homogeneous population and sample size was relatively small in spite of the lower mortality and morbidity rates. In addition, because we only obtained preoperative laboratory data, postoperative changes in HbA1c levels were not able to be investigated. However, this would be significant in terms of data from patients undergoing only isolated OPCAB.
These results do not contradict the importance of intensive glucose control therapy after CABG. However, preoperative intensive glycemic control therapy may not be useful for diabetic patients with abnormally elevated HbA1c. Early intervention and rehabilitation may help to improve survival after operations. In conclusion, elevated preoperative HbA1c levels were not associated with long-term mortality in diabetic patients with advanced atherosclerosis who underwent OPCAB. Preoperative only single measurement of HbA1c might not reflect the severity of coronary atherosclerosis in diabetic patients. Therefore, we believe that more careful evaluation for diabetes is needed in preoperative management of CABG.
